Vaccine adjuvant technology: from mechanistic concepts to practical applications

References

• Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54, 1–13 (1989).
   PubMedGoogle Scholar
• Schijns VEJC. Immunological concepts of vaccine adjuvant activity. C1.117:Opin. Immunol 12,456–463 (2000).
   Google Scholar
• Schijns VEJC. Induction and direction of immune responses by vaccine adjuvants.Grit. Rev Immunol 21, 75–85 (2002).
   Web of Science ®Google Scholar
• Steinman RM, Metlay J, Bhardwaj N et al. In: Dendritic cells: Natum's adjuvant. Janeway CA Jr, Sercarz EE, Sprent J (Eds.) Alan R. Liss/Wiley & Sons, New York, NY, USA, 155–165 (1998).
   Google Scholar
• Bretscher P, Cohn M. A theory of self-non-self discrimination. Science169, 1042–1049 (1970).
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM, EMS, Aichele Oehen, P. Kundig, S. Hengarten, T. H. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of the immune system. Immunol Rev. 156, 199–209 (1997).
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM. Localization dose and time of antigens determine immune reactivity. Semin. Immuno112,163–171 (2000).
   Google Scholar
• Karrer U, Althage A, Odermatt B et al On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox mutant mice. I Exp. Med. 185, 2175–2170 (1997).
   Web of Science ®Google Scholar
• Ochsenbein AF, Linschewer DD, Odermatt B, Ciurrea A, Hengartner H, Zinkernagel RM. Correlation of T-cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: Implications for splenectornized patients and vaccine design. hrimunol 164, 6296–6302 (2000).
   Google Scholar
• Kandig TM, Bachmann MF, DiPaolo C et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268, 1343–1347 (1995).
   PubMed Web of Science ®Google Scholar
• Freund J, Casals J, Page-Hosmer E. Sensitization and antibody formatio after injection of tubercle bacilli and paraffin oil. Proc. Soc. Exp. Biol. Med. 37, 509–513 (1937).
   Google Scholar
• Herbert WJ. Antigenicity of soluble protein in the presence of high levels of antibody: a possible mode of action of the antigen adjuvants. Nature 210, 7247–748 (1966).
   Web of Science ®Google Scholar
• Herbert WJ. The mode of action of mineral oil emulsion adjuvants on antibody production in mice. Immunology14, 301–318 (1968).
   PubMed Web of Science ®Google Scholar
• Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today13, 11–16 (1992).
   PubMedGoogle Scholar
• Matzinger P Tolerance, danger and the extended family. Ann. Rev Irrimuno112, 991–1045 (1994).
   Google Scholar
• Gallucci S, Lolkema M, Matzinger P Natural adjuvants: endogenous activators of dendritic cells. Nat. Med 5, 1249–1252 (1999).
   PubMed Web of Science ®Google Scholar
• Bachmann NE, Kopf M. The role of B-cells in acute and chronc infections. C1.117: Opion. Immunol 11, 332–339 (1999).
   Google Scholar
• Siegrist CA, Barrios C, Martinez X et al. Influence of maternal antibodies on vaccine response: inhibition of antibody but not T-cell responses allows succesful early prime-boost strategies in mice. Eur j Immunol 28, 4138–4148 (1998).
   PubMed Web of Science ®Google Scholar
• Morris W, Steinhoff MC, Russel PK. Potential of polymer microcapsulation technology for vaccine innovation. Vaccine 12, 5–11 (1994).
   PubMed Web of Science ®Google Scholar
• Langer R. New methods of drug delivery. Science 249, 1527–1533 (1990).
   PubMed Web of Science ®Google Scholar
• Le Moignic, Pinoy. Les vaccins en emulsion dans les corps gras ou `lipo-vaccins'. Comptes Rendus Soc. Biol. 79, 201–203 (1916).
   Google Scholar
• Freund J, Cascals J, Hosmer EP Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Floc Sx. Exp. Biol. Med 37, 509–513 (1937).
   Google Scholar
• Dupuis M, Murphy TJ, Higgins D et al. Dendritic cells internalize vaccine adjuvant after im. injection. Cell. Immunol 186, 18–27 (1998).
   PubMed Web of Science ®Google Scholar
• Whitehouse MW Orr KJ, Beck FVVJ, Pearson CM. Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology27, 311–330 (1974).
   PubMed Web of Science ®Google Scholar
• Bromford R. The adjuvant activity of fatty acid esters. The role of acyl chain length and degree of saturation. Immunology 44, 187–192 (1981).
   Google Scholar
• Shaw CM, Alvord EC, Keis MW Straight chain hydrocarbons as substitutes for the oil in Freund's adjuvants in the production of experimental 'allergic' encephalomyelitis in the guinea-pig. J. Immunol 92,24–27 (1964).
   PubMed Web of Science ®Google Scholar
• Yip HC, Karulin AY, Tary-Lehmann M et al. Adjuvant-guided type-land type-2 immunity: infectious/noninfectious dichotomy defines the class of response. Immunol 162,3942–3949 (1999).
   Web of Science ®Google Scholar
• Jankovic D, Liu Z, Gause WC. Th-1 and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. 7i-ends Immunol 22,450–457 (2001).
   Google Scholar
• Lascelles AK, Eagleson G, Beh KJ, Watson DL. Significance of Freund's adjuvant/antigen injection granuloma in the maintenance of serum antibody response. 4t. Immunol Immunopathol 22, 15–27 (1989).
   Google Scholar
• Florence AT, Law TK, Whateley TL. Nonaqueous foam structures from osmotically swollen W/O/VV emulsion droplets. .1. Colloid Interface Sri. 107, 584–588 (1985).
   Google Scholar
• Garti N, Aserin A, Cohen Y. Mechanistic Considerations on the release of electrolytes from multiple emulsions stabilised by BSA and nonionic surfactants. J. Controlled Release 29,41–51 (1994).
   Google Scholar
• Bjerregaard S, Soderberg I, Vermehren C, Frokjaer S. Formulation and evaluation of release and swell mechanism of a water-in-oil emulsion using factorial design. int. J. Pharm. 193,1–11 (1999).
   PubMed Web of Science ®Google Scholar
• Aucouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 19,2666–2672 (2001).
   PubMed Web of Science ®Google Scholar
• McKercher PD, Oil adjuvants: Their use in veterinary biologics. In: Advances in carriers and adjuvants for veterinary biologics. Nervig RM, Gough PM, Kaeberle ML et al. (Eds) Iowa State University Press, Ames, USA, 115–128 (1986).
   Google Scholar
• Murray R, Cohen P, Hardegree MC. Mineral oil adjuvants: biological and chemical studies. Ann. Allergy30, 146–151 (1972).
   Google Scholar
• Tengerdy RP, Lacetera NG. Vitamin E adjuvant formulations in mice, Vaccine 9, 204–206 (1991).
   Google Scholar
• Page WF, Norman JE, Benenson AS. Long-term follow-up of army recruits immunized with Freund's incomplete adjuvanted vaccine. Vaccine Res. 2,141–149 (1993).
   Google Scholar
• De Luka M, Groosiord JL, Medard JM Vaution C, Seiller M. A stable W/O/VV multiple emulsion. Cosmetics Toiletries 105, 65–66 (1990).
   Google Scholar
• Moingeon P, Haensler J, Lindberg A. Towards the rational design of Thl adjuvants. Vaccine 19,4363–4372 (2001).
   PubMed Web of Science ®Google Scholar
• Min W, Lillehoj HS, Burnside J, Weining KC, Staeheli P, Zhu JJ. Adjuvant effects of IL-10, IL-2, IL-8, IL-15, IFN-alpha, IFN-y TGF-134 and lymphotactin on DNA vaccination against Dmeria acervulina. Vaccine 20,267–274 (2001).
   PubMed Web of Science ®Google Scholar
• Sin J, Kim JJ, Pachuk C, Satishchandran C, Weiner DB. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Thl-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus Type 2 in vivo. J. Viral. 74, 11173–11180 (2000).
   Google Scholar
• Leutenegger CM, Boretti FS, Mislin CN et al. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. J. Viral. 74,10447-10457 (2000).
   Google Scholar
• Schijns VEJC, Weining KC, Nuijten P, Rijke EO, Staeheli P Immunoadjuvant activities of E. coil- and plasmid-expressed recombinant chickenIFN-y and IL-lbeta in 1-day- and 3-week-old chickens. Vaccine 18, 2147–2154 (2000).
   Google Scholar
• Nobiron I, Thompson I, Brownlie J, Collins ME. Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice. Vaccine 19, 4226–4235 (2001).
   PubMed Web of Science ®Google Scholar
• Scheerlinck JP, Casey G, McWaters P et al. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19,4053–4060 (2001).
   PubMed Web of Science ®Google Scholar
• Nohria A, Rubin RII. Cytokines as potential vaccine adjuvants. Biotherapy7, 261–269 (1994).
   PubMedGoogle Scholar
• Kim JJ, Bagarazzi ML, Trivedi N et al. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol 15,641–646 (1997).
   PubMed Web of Science ®Google Scholar
• Staudt LM, Brown PO. Genomic views of the immune system. Ann. Rev Immunol 18,829–859 (2000).
   PubMed Web of Science ®Google Scholar
• Harris AJ, Shaddock JG, Manjanatha MG, Lisenbey JA, Casciano DA. Identification of differentially expressed genes in aflatoxin Bl-treated cultured primary rat hepatocytes and Fischer 344 rats. Carrinogenesis 19, 1451–1458 (1998).
   Google Scholar
• Schena M, Shalon D, Davis RVV, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270,467–470 (1995).
   PubMed Web of Science ®Google Scholar
• Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971 (1992).
   PubMed Web of Science ®Google Scholar
• Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22,5640–5648 (1994).
   PubMed Web of Science ®Google Scholar
• Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 259,946–951 (1993).
   Google Scholar
• Diatchenko L, Lau YF, Campbell AP et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Li. USA 93, 6025–6030 (1996).
   PubMed Web of Science ®Google Scholar
• Krieg AM, Davis HL. Enhancing vaccines with immune stimulatory CpG DNA. Cur Opin. Mal Ther. 3, 15–24 (2001).
   PubMedGoogle Scholar